Prolistem® approved by JFDA

We are thrilled to announce that Prolistem®, developed by Medhija LLC, has received approval from the Jordan Food and Drug Administration (JFDA).

We are pleased to introduce Robou Yabroud Medical EST.
as our official distributor in Jordan

For more information and treatment protocols contact Jordan official distributor:
ROBOU YABROUD MEDICAL EST.
Mohmmad Al Abed
Phone: 00962777721006
Email: mohammadalabed432@gmail.com
Address: Ash Shumayasani near the Specality Hospital, Amman, Jordan

The Jordan Food and Drug Administration (JFDA) follows a rigorous approval process for supplements to ensure the safety and quality of these products. The JFDA’s primary objective is to safeguard public health by regulating the sale and distribution of supplements in Jordan. The approval process involves the following key steps:

1. Submission of Application: Supplement manufacturers or distributors submit an application to the JFDA, providing comprehensive information about the product, including its formulation, ingredients, intended use, dosage, and labeling.

2. Evaluation of Documentation: The JFDA carefully evaluates the submitted documentation, which includes scientific data, clinical studies, and toxicological information. This assessment helps determine the product’s safety and efficacy.

3. Quality Assessment: The JFDA conducts an evaluation of the supplement’s manufacturing process, ensuring compliance with Good Manufacturing Practices (GMP). This assessment ensures that the product is produced under controlled conditions, adhering to quality standards.

4. Labeling and Packaging Review: The JFDA reviews the labeling and packaging of the supplement to verify that it provides accurate information, including ingredient lists, dosage instructions, and any necessary warnings or precautions.

5. Safety and Efficacy Evaluation: The JFDA assesses the safety and efficacy of the supplement based on the provided scientific data and clinical studies. This evaluation helps determine whether the supplement offers the claimed benefits without posing significant health risks.

6. Post-Market Surveillance: After the supplement receives approval, the JFDA continues to monitor its safety and quality through post-market surveillance. This involves conducting inspections, analyzing adverse event reports, and taking appropriate regulatory actions if necessary.

By following this comprehensive approval process, the JFDA ensures that only safe and effective supplements reach the market, allowing consumers in Jordan to make informed choices about their health and well-being.